Aravive, Inc.
Aravive, Inc. (ARAV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ARAV · as of Jun 9, 2026
Key Statistics
Explore Aravive, Inc. Data
arav stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 18 · Buy rate: 44.4%
The ARAV analyst consensus is Hold, based on ratings from 18 Wall Street analysts over the past 3 months. The average 12-month price target is $0.25, representing +523.44% upside from the current price of $0.04.
Competitors & Peers
arav competitorsARAV
AFMD
APTO
BCEL
EIGRQ
IDRAStock Performance
Full HistoryAbout Aravive, Inc.
Aravive, Inc. is a clinical-stage biopharmaceutical company, based in Houston, Texas, dedicated to discovering and developing innovative treatments for life-threatening illnesses such as cancer and fi…
what is aravive, inc. · arav stock overview · aravive, inc. company profile · who is aravive, inc. ceo · arav NASDAQ · aravive, inc. headquarters · aravive, inc. business segments
About Stock Overview & Key Data
Aravive, Inc. (ARAV) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 21, 2014. As of the latest trading session, ARAV stock price is $0.04, with a market capitalization of $2.9M. The stock has returned -97.94% over the past 12 months and -68.96% year-to-date.
According to 18 Wall Street analysts, the consensus rating for Aravive, Inc. stock is Hold, with an average 12-month price target of $0.25. In fiscal year 2022, Aravive, Inc. reported revenue of $9.1M and net income of -$80.9M. For detailed data — including Aravive, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Aravive, Inc. (ARAV) stock price is $0.04. The stock is traded on NASDAQ under the ticker symbol ARAV. The 52-week range is $0.04 – $2.46.